Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Konecranes the first Finnish company to join CIRCit - a Nordic research project around circular economy

Konecranes the first Finnish company to join CIRCit - a Nordic research project around circular economy Konecranes has been accepted as a tier 1 company in the CIRCit research project. With operations in the Nordic countries, the CIRCit project supports Nordic companies to discover opportunities within circular economy. The goal is that the Nordic industry will establish itself as a forerunner in the area and at the same time strengthen its position in a highly competitive market. In the project, Konecranes will together with the CIRCit research team from leading universities,

Transforming with new technologies

A recent investment, making the most of the latest digital technologies managing the day to day running of the business for Lesjöfors company European Springs & Pressings, has empowered staff in the Cornwall factory to rise to the challenge that improvements are perpetual. Introducing FactoryWiz live, a monitoring and data collection system, streaming live data on large projection screens on the factory floor, has enabled operating personnel to meet their daily targets with far higher efficiencies.Michael Gibbs, Managing Director of Cornwall says: “FactoryWiz monitoring is a powerful

5G on a roll, cellular IoT deployments ramping up – Ericsson Mobility Report

· 3.5 billion IoT cellular connections predicted for 2023 · 5G commercial launches this year; North America seen leading the 5G uptake · 20 percent of global mobile data traffic will be on 5G networks in 2023Commercial rollouts of 5G and larger than previously forecasted deployments of cellular IoT are focal points in the latest edition of the Ericsson (NASDAQ: ERIC) Mobility Report. The forecast for cellular IoT connections has nearly doubled since November 2017. It is now expected to reach an estimated 3.5 billion in 2023, driven by ongoing large-scale deployments in China. New

Minium and Exactpro partner to perform Advanced Quality Assurance on Minium’s Clearing Risk Management & Post-Trade Processing systems

· Minium Financial Technology (“Minium”), a Cinnober Group company, offers real-time risk management and post-trade processing service for clearers and prime brokers, delivered as a Software as a Service (“SaaS”) product to allow clients to harness the power of the Cloud. · Partnership with Exactpro provides independent functional and non-functional testing, offering Minium’s clients the highest level of transparency and confidence in the quality of the Minium system.  Minium and Exactpro Systems Limited (Exactpro) today announced that they have entered into a partnership under

KONGSBERG receives order for deliveries to F-35 Joint Strike Fighter worth 525 MNOK

Kongsberg Defence & Aerospace AS (KONGSBERG) today received an order from Lockheed Martin valued at 525 MNOK for deliveries of more than 150 F-35 Joint Strike Fighter aircraft.The order consists of deliveries of aircraft structural parts in the form of Rudders and Vertical Leading Edges for the LRIP 11 production Lot and represents a continuation of previous orders for F-35, where Kongsberg has delivered parts since the LRIP 3 production Lot. “This order demonstrates KONGSBERG’s continued competitiveness of high end manufacturing for the F-35 program. We are also pleased to see how the

As a part of the bonus programme for corporate management, the following primary insiders have purchased Multiconsult shares

As a part of the management bonus allocation for 2017, the following primary insiders have purchased Multiconsult shares:Christian Nørgaard Madsen, CEO, purchased 3 100 shares.After the transaction he holds 54 222 shares. Anne Harris, CFO, purchased 1 192 shares.After the transaction she holds 11 865 shares. Grethe Bergly, EVP Greater Oslo, purchased 1 194 shares.After the transaction she holds 26 011 shares. Lars Opsahl, EVP Regions Norway, purchased 974 shares.After the transaction he holds 59 508 shares. Øyvind Holtedahl, EVP Marketing, Strategy & Innovation,

AcuCort’s allergy treatment Dexa ODF is ready to be manufactured according to GMP (Good Manufacturing Practice) for clinical use

AcuCort AB (AktieTorget: ACUC) today announces that the company has finalized the scaling-up of the manufacturing process for its drug candidate, the fast-dissolving oral film Dexa ODF to be placed on the tongue for the treatment of acute allergic reactions, and thereby is ready for manufacturing according to GMP (Good Manufacturing Practice) for clinical use in preparation of planned registration applications.Since May 2017, AcuCort has collaborated with the manufacturing partner Adhex Pharma with the goal to establish a manufacturing process for Dexa ODF that meets the requirements for

Global Gaming Malta are doing it again

Sliema, Malta, 12 June 2018 - The growing Swedish company is attracting talent from very respectable competitors. This time, it is our pleasure to announce the appointment from Betsson of Vladimir Camilleri, Head of Data and Christine Cassar, Senior Product Owner, as well as the latest recruitment from GIG, Ryan Sultana, Head of Projects.‘We’re growing, there can be no doubt about it. And we’re very aware that, in order to build the competitive product offering we have in the pipeline, it is imperative that we carefully select only the very best candidates.’ are the words with which proud

Press invitation: HYBRIT - construction start on a globally unique pilot plant for fossil free steel production in Luleå, Sweden

On Wednesday 20 June 2018, the groundbreaking will be held for a globally unique pilot plant within the fossil free steel initiative undertaken by HYBRIT, SSAB, LKAB and Vattenfall. Speaking at the ceremony will be Swedish Prime Minister Stefan Löfven. Also taking part will be Deputy Prime Minister Isabella Lövin, HYBRIT CEO Mårten Görnerup, SSAB CEO and Group Manager Martin Lindqvist, LKAB CEO and Group Manager Jan Moström, and Vattenfall CEO and Group Manager Magnus Hall. Place: SSAB Luleå, Svartövägen 20, Luleå, SwedenDate: Wednesday, 20 June 2018, 10:00 – 13:00 Opportunities

Bonava to develop new neighbourhood in Espoo, Finland

Bonava has signed a binding pre-agreement with Kemira’s pension fund Neliapila enabling Bonava, in cooperation with Neliapila and Kemira, to develop a new neighborhood in the Finnoo district of Espoo that will become approximately 50,000 m2. The area is scheduled for completion around 2030.-  It pleases me to note that Espoo and Finnoo are continuing to grow as an attractive area, and we look forward to being active there. We can see that there is demand in the area for affordable housing where people have the highest quality of life, which is something we will now offer in Finnoo, says

Volvo receives largest ever order for hybrid buses

Volvo Buses’ North American subsidiary, Nova Bus, has received an order for 497 hybrid buses from the transit authorities in Quebec in Canada. This is the single largest order for hybrid vehicles for the Volvo Group to date. The order encompasses an option for a further 1,028 vehicles. Deliveries will take place 2020-2025.With a total of more than 5,500 electrified buses sold world over (4,000 under the Volvo brand and 1,500 under the Nova Bus brand excluding the new order), Volvo Buses is one of the world leaders in the fast-expanding market of electrified buses. The company’s subsidiary,

Change in number of shares in Camanio Care AB (publ)

Conversion of convertible notes into shares under the Convertible Notes issued within the financing agreement announced on December 6th 2017.The date of conversion was June 11th 2018 and the number of Notes converted was 30. The number of Notes remaining under the first Tranche for future conversion is 200. The number of shares and the number of votes before the conversion was 16,452,317.  Through the conversion the number of shares and the number of votes has increased by 222,222. The total number of shares and the total number of votes after the conversion amount to 16,674,539.

Sectra successfully completes unique nationwide telepathology solution in the Netherlands

Linköping, Sweden – June 12, 2018 –  International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has completed the unique nationwide telepathology solution in the Netherlands , PIE. The final part of the solution, which enables automatic upload of all images connected to a case, has now been approved and released. Pathology laboratories all over the Netherlands can connect to the solution and share digital pathology images to carry out consultations and revisions, and

Alfa Laval wins SEK 85 million energy efficiency order

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won an order to supply Alfa Laval Packinox heat exchangers to a refinery in the US. The order has a value of approximately SEK 85 million. It is booked in the Welded Heat Exchanger unit of the Energy Division, with deliveries scheduled for 2019.The order comprises compact heat exchangers for energy recovery in a chemical process, where low octane refinery naphtha’s are converted into high-octane liquid products. “I am happy about this order for our energy-efficient and compact heat exchangers,”

Fiskars appoints Tuomas Hyyryläinen as Chief Growth Officer and member of the Fiskars Group Leadership Team

Fiskars CorporationStock Exchange ReleaseJune 12, 2018 at 9:30 EEST Fiskars appoints Tuomas Hyyryläinen as Chief Growth Officer and member of the Fiskars Group Leadership Team Fiskars has appointed Tuomas Hyyryläinen as Chief Growth Officer and member of the Fiskars Group Leadership Team (FGLT) from September 1, 2018. He will report to Fiskars President and CEO Jaana Tuominen. ″During the past years Fiskars has focused on structural changes, building common platforms and creating unified ways of working. As this work will continue, the existing foundation allows us to shift our

Camurus and Medison enter into commercialization agreement for CAM2038 in Israel

Lund, Sweden — 12 June 2018 — Camurus AB (Nasdaq STO, CAMX) and Medison Pharma Ltd. announced today an exclusive agreement to commercialize CAM2038 weekly and monthly buprenorphine depot injections in Israel. CAM2038 is being developed for the treatment of adults with moderate to severe opioid dependence, representing a huge global healthcare problem. Under terms of the agreement, Medison will have the exclusive right to commercialize CAM2038 in all indications, including opioid dependence and chronic pain, in Israel. Medison will also be responsible for obtaining regulatory approval for

Update: lanabecestat Phase III Alzheimer's trials

This announcement contains inside information 12 June 2018 07:00 BST Update on Phase III clinical trials of lanabecestat for Alzheimer's disease Independent data monitoring committee advises lanabecestat is unlikely to meet primary endpoints, leading to decision to discontinue these trials AstraZeneca and Eli Lilly and Company (Lilly) are discontinuing the global Phase III clinical trials of lanabecestat, an oral beta secretase cleaving enzyme (BACE) inhibitor, for the treatment of Alzheimer's disease. The decision is based on recommendations by an independent data monitoring

Capital markets day, 12 June 2018: Ferronordic presents its work with digitalization, employees and compliance

Press ReleaseStockholm, 12 June 2018Today, 12 June 2018, Ferronordic Machines AB (”Ferronordic”) arranges a capital markets day for analysts, investors and media to highlight how the company conducts a sustainable and increasingly digitalized business in Russia. Lars Corneliusson, CEO, starts the day with a general overview of the Russian market, the company’s operations and its aftermarket focus. Anders Blomqvist, CFO, describes the company’s financial targets, efficient use of capital and profitability development. Then follows a presentation of the four main themes of the day.

Targovax hosts conference call 12 June 2018

Oslo, Norway, 12 June 2018: Targovax ASA (“Targovax” or “the Company”; OSE: TRVX), a clinical stage company focused on developing and commercializing immune activating oncology therapies to target, primarily, treatment resistant solid tumors, today hosts a conference call to give an update to its clinical development strategy.For reference, please see the press release from 11 June 2018 here .The conference call will include a presentation from the

Starbreeze, Skybound Entertainment and 505 Games reveal November 2018 release for Overkill’s the Walking Dead

Pre-orders Available June 12 for Launch on Nov. 6 in the Americas and Nov. 8 Globally on PlayStation®4, Xbox One and Windows PC See the Upcoming Co-op Shooter in Action for the First Time in Debut Gameplay Trailer MEDIA BLAST - STOCKHOLM  – June 12, 2018 – Starbreeze, Skybound Entertainment and 505 Games have released the first official gameplay trailer for OVERKILL’s The Walking Dead, the upcoming cooperative multiplayer FPS from developer OVERKILL – A Starbreeze Studio. The video also reveals the game is expected to launch on the PlayStation®4 computer entertainment

Automotive company commits to Hexagon Composites as supplier to fuel-cell electric vehicles

Hexagon Composites will supply compressed hydrogen tanks for serial production of fuel cell electric vehicles (FCEV) to be launched by an automotive OEM.Hexagon is currently developing the tanks to support anticipated production activities as early as 2020. Production is planned to run for at least five years. Hexagon estimates the combined value for development and serial production to be in the range of USD 120 to 150 million (approximately NOK 1.0 billion to 1.2 billion)."This is a strategically important customer contract fulfilment for Hexagon and the growing FCEV industry. Hexagon

Nordic Nanovector Announces Betalutin® has been granted Fast Track designation in the US for Follicular Lymphoma

Oslo, Norway, 12 June 2018 Nordic Nanovector ASA (OSE: NANO) announces that the US Food & Drug Administration (FDA) has granted Fast Track designation to Betalutin® (177Lu-lilotomab satetraxetan) for the treatment of patients with relapsed or refractory follicular lymphoma (FL) after at least 2 prior systemic therapies. Lisa Rojkjaer MD, Nordic Nanovector CMO, commented: “We are pleased to have been granted Fast Track designation for Betalutin®. This designation is based on the promising safety and preliminary efficacy data in patients with relapsed/refractory indolent non-Hodgkin’s

Elekta Nomination Committee’s proposed Board of Directors for the 2018 Annual General Meeting

STOCKHOLM, June 12, 2018 – The Nomination Committee of Elekta (EKTA-B.ST) proposes that the 2018 Annual General Meeting re-elect Board members Laurent Leksell, who is also proposed to be re-elected as Chairman of the Board, Annika Espander Jansson, Caroline Leksell Cooke, Johan Malmquist, Tomas Puusepp, Wolfgang Reim, Jan Secher, Birgitta Stymne Göransson and elect Cecilia Wikström. Luciano Cattani has declined re-election. Cecilia Wikström has broad experience and knowledge of international – and especially European – business and social issues. She has been a Member of the European

UNITED THERAPEUTICS AND XVIVO PERFUSION ANNOUNCE COLLABORATION TO REDUCE ORGAN SHORTAGE THROUGH EXPANSION OF ORGAN EVALUATION SERVICE

Silver Spring, MD and Englewood, CO, June 12, 2018: United Therapeutics Corporation (Nasdaq: UTHR) and XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB (STO: XVIVO), today announced that the use of XVIVO’s ex-vivo lung perfusion (EVLP) technology will be incorporated into the Silver Spring, Maryland laboratory of Lung Bioengineering Inc., a subsidiary of United Therapeutics’ public benefit corporation subsidiary Lung Biotechnology PBC. “I am excited about trying to make more life-saving use of donated lungs via XVIVO Perfusion’s pioneering technology,” said Martine Rothblatt, Ph.

There are no items matching the current filter
There are no more items matching the current filter
Back to top